Gelteq(GELS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GELS Gelteq

Market Closed 12-12 16:00:00 EST

1.01

-0.08

-7.34%

盘后1.01

+0.000.00%

19:55 EST

High1.09	Low1.00	Vol40.67K
Open1.06	D1 Closing1.09	Amplitude8.25%
Mkt Cap10.82M	Tradable Cap4.82M	Total Shares10.71M
T/O42.49K	T/O Rate0.85%	Tradable Shares4.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GELS","market":"US","secType":"STK","nameCN":"Gelteq","latestPrice":1.01,"timestamp":1765573200000,"preClose":1.09,"halted":0,"volume":40666,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.01,"latestTime":"19:55 EST","volume":751,"amount":760.89,"timestamp":1765587354552},"delay":0,"floatShares":4772600,"shares":10711059,"eps":-0.472038,"marketStatus":"Market Closed","change":-0.08,"latestTime":"12-12 16:00:00 EST","open":1.06,"high":1.0899,"low":1,"amount":42493.6561046,"amplitude":0.082477,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.472038,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1710129600000,"exchange":"NASDAQ","adjPreClose":1.09,"preHourTrading":{"tag":"盘前","latestPrice":1.0464,"preClose":1.09,"latestTime":"09:04 EST","volume":107,"amount":113.3519908,"timestamp":1765548253815},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.01,"latestTime":"19:55 EST","volume":751,"amount":760.89,"timestamp":1765587354552},"volumeRatio":0.30757245684231965},"requestUrl":"/m/hq/s/GELS/wiki","defaultTab":"wiki","newsList":[{"id":"2590344247","title":"Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344247","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590344247?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:15","pubTimestamp":1765289721,"startTime":"0","endTime":"0","summary":"Gelteq Ltd., an innovator in gel-based oral delivery technologies, has announced the signing of a three-year sales agreement with Shenzhen Mana Health Management Co. Ltd. Under the agreement, Mana will distribute Gelteq's proprietary nutritional gel formulations in China, primarily focusing on a product aimed at sugar lowering. The contract includes minimum annual order volumes, with Gelteq expecting to generate at least USD $1.3 million in revenue over the term of the agreement. Mana will utilize its digital and offline retail channels to promote, market, and sell Gelteq's products across China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the original content used to generate this news brief via GlobeNewswire ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL2Y7gKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4007","LU2095319765.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4585","BK4588","GELS","NDAQ","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","BK4112","SG9999014005.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2590124344","title":"Gelteq Signs Three Year Sales Agreement With Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion Into China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590124344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590124344?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:15","pubTimestamp":1765289700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA1CRGZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2589816832","title":"Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2589816832","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589816832?lang=en_us&edition=fundamental","pubTime":"2025-12-05 23:30","pubTimestamp":1764948600,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Dec.  05, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/05/3200842/0/en/Gelteq-Preclinical-Study-Demonstrates-Enhanced-Oral-Delivery-of-Oil-Soluble-and-Poorly-Soluble-Drugs-Using-Its-Gel-Based-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","GELS","BK4007","BK4023","API","BK4535","BK4551"],"gpt_icon":0},{"id":"2588055228","title":"Gelteq to Present at Investor Summit Virtual on December 9, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588055228","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588055228?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:30","pubTimestamp":1764682200,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Dec.  02, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at theQ4 Investor Summi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197958/0/en/Gelteq-to-Present-at-Investor-Summit-Virtual-on-December-9-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HNW","SMMF","GELS","BK4007","BK4211"],"gpt_icon":0},{"id":"2585007467","title":"Gelteq announces ‘positive’ preclinical results for its gel formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2585007467","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585007467?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:45","pubTimestamp":1763991952,"startTime":"0","endTime":"0","summary":"The company states: “Gelteq (GELS) Limited announced positive preclinical results showing its proprietary gel formulation achieved substantially hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-announces-positive-preclinical-results-for-its-gel-formulation-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-announces-positive-preclinical-results-for-its-gel-formulation-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2585467508","title":"Gelteq Ltd - Formulation Shows 38-45% Increase in Systemic Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2585467508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585467508?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:31","pubTimestamp":1763991060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00EF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2585446752","title":"Gelteq Ltd: Anticipates Using These Results to Further Pursue FDA Approval Pathway for Antihistamine Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585446752?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:31","pubTimestamp":1763991060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00EF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2585946765","title":"Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2585946765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585946765?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:30","pubTimestamp":1763991000,"startTime":"0","endTime":"0","summary":"Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov.  24, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”),","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193490/0/en/Gelteq-Announces-Positive-Preclinical-Results-Demonstrating-Enhanced-Bioavailability-Using-Its-Proprietary-Gel-Based-Drug-Delivery-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS"],"gpt_icon":0},{"id":"2580797226","title":"Gelteq Ltd. Delays Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580797226","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580797226?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:01","pubTimestamp":1762207288,"startTime":"0","endTime":"0","summary":"Gelteq Limited has disclosed a delay in filing its required financial report. The company stated that the report could not be filed within the prescribed time period without unreasonable effort or expense but expects to file it within the allowed extension period. The specific financial period and form type were not provided in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDLbLnqQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2577079093","title":"Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2577079093","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577079093?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224400,"startTime":"0","endTime":"0","summary":"Collaboration with Monash University to Address a Large Pharmaceutical OpportunityMELBOURNE, Australia, Oct.  23, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172100/0/en/Gelteq-Announces-Commencement-of-Preclinical-Trial-Targeting-Oil-Soluble-Drug-Market-with-Novel-Delivery-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2574529141","title":"Gelteq enters Product Development, Profit Share Agreement with Melbourne Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2574529141","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574529141?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:21","pubTimestamp":1760012461,"startTime":"0","endTime":"0","summary":"Gelteq (GELS) announced it has entered into a Product Development and Profit Share Agreement, with Melbourne Health, operator of The Royal Melbourn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-enters-product-development-profit-share-agreement-with-melbourne-health-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-enters-product-development-profit-share-agreement-with-melbourne-health-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2574152998","title":"Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152998","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574152998?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:00","pubTimestamp":1760011200,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Oct.  09, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today anno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/09/3164076/0/en/Gelteq-Announces-New-Product-Development-Agreement-with-Melbourne-Health-for-Novel-Bowel-Polyp-Growth-Reduction-Compound.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2566897618","title":"Gelteq powers U.S. product launches of Healthy Extracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2566897618","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566897618?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:35","pubTimestamp":1757676939,"startTime":"0","endTime":"0","summary":"Gelteq (GELS) announces recent product launches of Healthy Extracts, whose products apply Gelteq’s proprietary gel technology, into the U.S. nutrac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-powers-u-s-product-launches-of-healthy-extracts-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-powers-u-s-product-launches-of-healthy-extracts-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2565674115","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2565674115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565674115?lang=en_us&edition=fundamental","pubTime":"2025-09-06 01:46","pubTimestamp":1757094387,"startTime":"0","endTime":"0","summary":"SINTX Technologies  said Wednesday it published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV.Shares surged about 36% as intraday trading volume soared to nearly 1.6 million from a daily average of roughly 746,000.Gelteq  said Friday it plans to commence a preclinical bioequivalence study in September to evaluate its gel-based formulation of a widely used antihistamine for allergy treatment.Shares surged about 64% as intraday trading volume soared to roughly 61.6 million from a daily average of about 1.41 million.Broadcom  posted a \"solid\" fiscal Q3, with a significant boost in orders related to AI infrastructure, Truist Securities said in a note emailed Friday.Broadcom gave several notable AI updates in its recent results, including the addition of a fourth infrastructure customer expected to add $10 billion in sales in H2 of fiscal 2026, ongoing 60% growth from e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5949003.HKD","LU1803068979.SGD","LU0057025933.USD","LU0965509010.AUD","LU0476273544.USD","LU2168564149.EUR","LU0444973449.USD","LU2125154778.USD","IE00BZ1G4Q59.USD","LU2237957811.SGD","LU2322448957.HKD","SG9999015952.SGD","LU1935042215.USD","LU0210536198.USD","LU0672654240.SGD","IE00BVYPNW00.USD","LU0320765646.SGD","LU2347655156.SGD","LU0345769128.USD","LU1145028129.USD","LU1323610961.USD","LU1551013342.USD","LU2487616109.SGD","BK4585","SINT","LU1242518857.USD","LU0354030438.USD","BK4598","LU0444971666.USD","LU0203202063.USD","LU1670627923.USD","LU1852331112.SGD","IE00BJTD4V19.USD","SG9999003800.SGD","LU2265009873.SGD","AVGO","LU2242650005.HKD","LU2750360641.GBP","LU1917777945.USD","LU0345770308.USD","LU0683600562.USD","IE00B7KXQ091.USD","GELS","LU2168564222.USD","LU0719512351.SGD","LU0964807845.USD","LU2430703095.HKD","LU0545039389.USD","LU2247934214.USD","IE0004445239.USD"],"gpt_icon":0},{"id":"2565856103","title":"BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2565856103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565856103?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:31","pubTimestamp":1757086317,"startTime":"0","endTime":"0","summary":"BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy MarketSept 5 (Reuters) - Gelteq Ltd GELS.O:GELTEQ ANNOUNCES COMMENCEMENT OF PRECLINICAL TRIAL FOR NOVEL GEL-BA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2565561753","title":"Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2565561753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565561753?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:27","pubTimestamp":1757086031,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2565561737","title":"Gelteq Ltd - Plans Human Trials for FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2565561737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565561737?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:27","pubTimestamp":1757086031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2553255463","title":"Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2553255463","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553255463?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:35","pubTimestamp":1753187720,"startTime":"0","endTime":"0","summary":"Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthy Extracts Inc. published the original content used to generate this news brief via ACCESS Newswire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL6byG76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","HYEX"],"gpt_icon":0},{"id":"2552481357","title":"Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2552481357","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552481357?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755400,"startTime":"0","endTime":"0","summary":"Partnership to support the scale-up and commercialization of Gelteq’s proprietary gel-based oral delivery platformNEW YORK, July  17, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117209/0/en/Gelteq-Announces-Agreement-with-IDT-Australia-to-Secure-Dedicated-New-Product-Development-and-Manufacturing-Facilities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","API","BK4023","GELS","BK4503","BK4535","IDT","BK4115","BK4551"],"gpt_icon":0},{"id":"2552109124","title":"IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2552109124","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552109124?lang=en_us&edition=fundamental","pubTime":"2025-07-17 15:39","pubTimestamp":1752737961,"startTime":"0","endTime":"0","summary":"IDT Australia  signed a memorandum of understanding with Gelteq for an Australian-based manufacturing facility to support the development and scale-up of the Nasdaq-listed firm's gel-based products, according to a Thursday Australian bourse filing.The agreement establishes a framework for Gelteq to develop a dedicated facility within IDT's manufacturing site. It provides facilities and equipment required for the manufacture of the products in a dedicated building and purpose-built facility funded by Gelteq, with trained staff and operational support.The firms anticipate a final binding agreement to be in place in the coming months.The firm's shares rose over 5% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK7501","XAO.AU","GELS","BK4115","IDT","XKO.AU","XJO.AU","IDT.AU","BK7096"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gelteq.com","stockEarnings":[{"period":"1week","weight":-0.0734},{"period":"1month","weight":-0.0472},{"period":"3month","weight":-0.3688},{"period":"6month","weight":-0.519},{"period":"1year","weight":-0.6689},{"period":"ytd","weight":-0.5647}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Gelteq","nameEN":"Gelteq"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gelteq(GELS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Gelteq(GELS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Gelteq,GELS,Gelteq股票,Gelteq股票老虎,Gelteq股票老虎国际,Gelteq行情,Gelteq股票行情,Gelteq股价,Gelteq股市,Gelteq股票价格,Gelteq股票交易,Gelteq股票购买,Gelteq股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gelteq(GELS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Gelteq(GELS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction